Medical Fellow in US Translational Medicine & Clinical Pharmacology (TMCP)

The Medical Fellowship Program designed to leverages the skillsets acquired in a PharmD training program to train Clinical Pharmacologist for a career in the pharmaceutical industry. The Fellow will be based at Boehringer Ingelheim’s U.S. headquarters in Ridgefield, CT, working on a particular or multiple therapeutic areas (TAs) in the areas of cardiology, diabetes, immunology, oncology, and respiratory. This position will provide an opportunity for the Fellow to involve in various cross functional teams within BI and hence the Fellow will also gain an understanding of the broad range of opportunities available to a pharmacist in the pharmaceutical industry.

Position Accountability:

• Work under the mentorship of a senior clinical pharmacologist in various aspects of drug development from clinical pharmacology perspective.

• Develop a sound understanding and application of global regulatory guidance (FDA, EMA, PMDA, etc) that are essential in designing drug development strategy and at the same time serve as a framework for drug development from clinical pharmacology perspective. For instance, understanding and applying the drug-drug interaction guidances to conceptualize the drug interaction risk of a new drug under development and subsequently design appropriate trials to elucidate the risk clinically.

• Serve as a responsible clinical pharmacologist; design the clinical PK/PD aspects of the clinical trial protocol (trials in healthy volunteers/patients) as well as analyze and interpret Clinical PK/PD results (e.g., food effect study, drug-drug interaction study, formulation bridging study, single rising dose study, etc).

• Undertake a review of literature to find solutions to scientific challenges/to design clinical trial/project strategies.

• Author clinical pharmacology sections of documents such as clinical trial protocols, clinical trial reports, investigator brochure, response to authority requests, etc.

• Present internally as well as externally (for instance, presentation at professional clinical pharmacology meetings) and coauthor scientific manuscripts depending on project needs.